1. OC-16: Comparison of VTE recurrence, bleeding-related hospitalization and all-cause mortality in patients with active cancer in two patient populations, based upon cancer types considered to have high and low risks of bleeding, receiving DOACs or LMWH: The OSCAR UK Study. Issue 213 (May 2022) Authors: Cohen, A.T.; Wallenhorst, C.; Ay, C.; Schaefer, B.; Abdelgawwad, K.; Psaroudakis, G.; Brobert, G.; Coleman, C.I.; Ekbom, A.; Lee, A.Y.Y.; Khorana, A.A.; Becattini, C.; Carrier, M.; Rivera, M.; Martinez, C. Journal: Thrombosis research Issue: Issue 213(2022)Supplement 2 Page Start: S9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PO-20 Incidence of venous thromboembolism in men with prostate cancer and men without prostate cancer: a nationwide population-based cohort study in Sweden. Issue 200 (April 2021) Authors: Farahmand, B.; Balabanova, Y.; Stattin, P.; Garmo, H.; Brobert, G. Journal: Thrombosis research Issue: Issue 200(2021)Supplement 1 Page Start: S27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-45 Long-term anticoagulation for the treatment and secondary prophylaxis of venous thromboembolism among men with prostate cancer in Sweden: risk of recurrent venous thromboembolism and major bleeding. Issue 200 (April 2021) Authors: Brobert, G.; Farahmand, B.; Stattin, P.; Garmo, H.; Balabanova, Y. Journal: Thrombosis research Issue: Issue 200(2021)Supplement 1 Page Start: S40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗